Antitumor effect of photodynamic therapy with a novel targeted photosensitizer on cervical carcinoma

Oncology Reports

Volumn 33, Issue 1, 2015, Pages 125-132

  Li, Peng Xi ^a   Mu, Jiang Hong ^a   Xiao, Hua Lang ^a   Li, Dong Hong ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Antitumor activity; Apoptosis; Cervical cancer; Photosensitizer I; Tumor targeting

Indexed keywords

FOLATE RECEPTOR; FOLIC ACID; PHOTOSENSITIZING AGENT; TERT BUTYL N POLY(ETHYLENEGLYCOL)ETHYLCARBAMATE 5,10,15 TRIS(3 HYDROXYPHENYL) 20 (4 CARBOXYPHENYL)CHLORIN; UNCLASSIFIED DRUG; [GAMMA [N POLY(ETHYLENEGLYCOL)]FOLIC ACID] 5,10,15 TRIS(3 HYDROXYPHENYL) 20 (4 CARBOXYPHENYL)CHLORIN; PORPHYRIN; PS I PHOTOSENSITIZER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG TARGETING; ENDOCYTOSIS; FEMALE; HELA CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIGHT EXPOSURE; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; RADIATION DOSE; TUMOR VOLUME; UTERINE CERVIX CARCINOMA; ANIMAL; BAGG ALBINO MOUSE; DRUG SCREENING; NUDE MOUSE; PATHOLOGY; PHOTOCHEMOTHERAPY; TISSUE DISTRIBUTION; UTERINE CERVICAL NEOPLASMS;

ANIMALS; APOPTOSIS; FEMALE; HELA CELLS; HUMANS; MICE, INBRED BALB C; MICE, NUDE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; TISSUE DISTRIBUTION; UTERINE CERVICAL NEOPLASMS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84916206821     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.3593     Document Type: Article

References (27)

1. Downs LS, Smith JS, Scarinci I, Flowers L and Parham G: The disparity of cervical cancer in diverse populations. Gynecol Oncol 109: 22-30, 2008.
2. Wells SF: Cervical cancer: an overview with suggested practice and policy goals. Medsurg Nurs 17: 43-50, 2008.
3. He GF, Bian ML, Zhao YW, Xiang Q, Li HY and Xiao C: A study on the mechanism of 5-aminolevulinic acid photodynamic therapy in vitro and in vivo in cervical cancer. Oncol Rep 21: 861-868, 2009.
4. Fayter D, Corbett M, Heirs M, Fox D and Eastwood A: A systematic review of photodynamic therapy in the treatment of pre-cancerous skin conditions, Barrett's oesophagus and cancers of the biliary tract, brain, head and neck, lung, oesophagus and skin. Health Technol Asses 14: 1-288, 2010.
5. Benov L: Photodynamic therapy: current status and future directions. Med Princ Pract: May 10, 2014 (Epub ahead of print). doi: 10.1159/000362416.
6. Syu WJ, Yu HP, Hsu CY, et al: Improved photodynamic cancer treatment by folate conjugated polymeric micelles in a KB xenografted animal model. Small 8: 2060-2069, 2012.
7. Dabrowski JM, Arnaut LG, Pereira MM, Monteiro CJ, Urbanska K, Simoes S and Stochel G: New halogenated water-soluble chlorin and bacteriochlorin as photostable PDT sensitizers: synthesis, spectroscopy, photophysics, and in vitro photosensitizing efficacy. ChemMedChem 5: 1770-1780, 2010.
8. Eshghi H, Sazgarnia MSc A, Rahimizadeh M, Attaran N, Bakavoli M and Soudmand S: Protoporphydin IX-gold nanoparticle conjugates as an efficient photosensitizer in cervial cancer therapy. Photodiagnosis Photodyn Ther 10: 304-312, 2013.
9. Shupin-Mrugalska P, Piskorz J, Goslinski T, Mielcarek J, Konopka K and Düzgünes N: Current status of liposomal porphyrinoid photosensitizers. Drug Discov Today 18: 776-784, 2013.
10. Gijsens A, Missiaen L, Merlevede W and de Witte P: Epidermal growth factor-mediated targeting of chlorin e6 selectively potentiates its photodynamic activity. Cancer Res 60: 2197-2202, 2000.
11. Stefflova K, Li H, Chen J and Zheng G: Peptide-based pharmacomodulation of a cancer-targeted optical imaging and photodynamic therapy agent. Bioconjug Chem 18: 379-388, 2007.
12. Vrouenraets MB, Visser GWM, Loup C, et al: Targeting of a hydrophilic photosensitizer by use of internalizing monoclonal antibodies: A new possibility for use in photodynamic therapy. Int J Cancer 88: 108-114, 2000.
13. McCarthy JR, Bhaumik J, Merbouh N and Weissleder R: High-yielding syntheses of hydrophilic, conjugatable chlorins and bacteriochlorins. Org Biomol Chem 7: 3430-3436, 2009.
14. Vlahov IR and Leamon CP: Engineering folate-drug conjugates to target cancer: from chemistry to clinic. Bioconjug Chem 23: 1357-1369, 2012.
15. Bugaj AM: Targeted photodynamic therapy - A promising strategy of tumor treatment. Photochem Photobiol Sci 10: 1097-1109, 2011.
16. Leung WN, Sun X, Mak NK and Yow CM: Photodynamic effects of mTHPC on human colon adenocarcinoma cells: photocytotoxicity, subcellular localization and apoptosis. Photochem Photobiol 75: 406-411, 2002.
17. Wang L, Li M and Zhang N: Folate-targeted docetaxel-lipidbased-nanosuspensions for active-targeted cancer therapy. Int J Nanomedicine 7: 3281-3294, 2012.
18. Li D, LI P, Lin H, Jiang Z, Guo L and Li B: A novel chlorin-PEGfolate conjugate with higher water solubility, lower cytotoxicity, better tumor targeting and photodynamic activity. J Photochem Photobiol B 127: 28-37, 2013.
19. Vaidya A, Sun Y, Feng Y, Emerson L, Jeong EK and Lu ZR: Contrast-enhanced MRI-guided photodynamic cancer therapy with a pegylated bifunctional polymer conjugate. Pharm Res 25: 2002-2011, 2008.
20. Chin WWL, Heng PWS, Thong PSP, et al: Improved formulation of photosensitizer chlorin e6 polyvinylpyrrolidone for fluorescence diagnostic imaging and photodynamic therapy of human cancer, Eur J Pharm Biopharm 69: 1083-1093, 2008.
21. Gui T, Wang Y, Mao Y, Liu J, Sun S, Cao D, Yang J and Shen K: Comparisons of 5-aminolevulinic acid photodynamic therapy and after-loading radiotherapy in vivo in cervical cancer. Clin Transl Oncol 15: 434-442, 2013.
22. Hiorth M, Liereng L, Reinertsen R and Tho I: Formulation of bioadhesive hexylaminolevulinate pellets intended for photodynamic therapy in treatment of cervical cancer. Int J Pharm 441: 544-554, 2013.
23. Saul JM, Annapragada A, Natarajan JV and Bellamkonda RV: Controlled targeting of liposomal doxorubicin via the folate receptor in vitro. J Control Release 92: 49-67, 2003.
24. Westermann P, Glanzmann T, Andrejevic S, et al: Long circulating half-life and high tumor selectivity of the photosensitizer meta-tetrahydroxyphenylchlorin conjugated to polyethylene glycol in nude mice grafted with a human colon carcinoma. Int J Cancer 76: 842-850, 1998.
25. Evensen JF, Moan J, Hindar A and Sommer S: Tissue distribution of 3H-hematoporphyrin derivative and its main components, 67Ga-and 131I-albumin in mice bearing Lewis lung carcinoma. Prog Clin Biol Res 170: 541-562, 1984.
26. Leamon CP and Reddy JA: Folate-targeted chemotherapy. Adv Drug Deliv Rev 56: 1127-1141, 2004.
27. Zhang JL, Deng L, Yao JZ, et al: Synthesis and photobiological study of a novel chlorin photosensitizer BCPD-18MA for photodynamic therapy. Bioorg Med Chem 19: 5520-5528, 2011.